Virus inoculation and treatment regimens for evaluating anti-filovirus monoclonal antibody efficacy in vivo

The development of monoclonal antibodies to treat disease caused by filoviruses, particularly Ebola virus, has risen steeply in recent years thanks to several key studies demonstrating their remarkable therapeutic potential. The increased drive to develop new and better monoclonal antibodies has nec...

Descripción completa

Detalles Bibliográficos
Autores principales: Banadyga, Logan, Schiffman, Zachary, He, Shihua, Qiu, Xiangguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association Publishing House. Published by Elsevier B.V. 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347303/
https://www.ncbi.nlm.nih.gov/pubmed/32835206
http://dx.doi.org/10.1016/j.bsheal.2019.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347303/
https://www.ncbi.nlm.nih.gov/pubmed/32835206
http://dx.doi.org/10.1016/j.bsheal.2019.02.004

Ejemplares similares